Sign In
Sign In
Forgot Password
Or
Cancel
Sign In
Enter Reason Of Report:
Report Now!
UK health regulator approves GSK’s vaccine for common respiratory virus RSV
Home
Healthcare
UK health regulator approves GSK’s vaccine for common respiratory virus RSV
Healthcare
halaalcommerce.com
No Comments
10 July 2023
The Medicines and Healthcare products Regulatory Agency (MHRA) authorised GSK’s shot, called Arexvy, for active immunisation to prevent lower respiratory tract disease caused by RSV in adults 60 years and older.
#healthcare
Previous
Next
There is no widget. You should add your widgets into
Default
sidebar area on
Appearance => Widgets
of your dashboard.